Literature DB >> 27094359

Device Longevity in a Contemporary Cohort of ICD/CRT-D Patients Undergoing Device Replacement.

Francesco Zanon1, Cristian Martignani2, Ernesto Ammendola3, Endrj Menardi4, Maria Lucia Narducci5, Paolo DE Filippo6, Matteo Santamaria7, Andrea Campana8, Giuseppe Stabile9, Domenico Rosario Potenza10, Gianni Pastore1, Matteo Iori11, Concetto LA Rosa12, Mauro Biffi2.   

Abstract

INTRODUCTION: The longevity of defibrillators (ICD) is extremely important from both a clinical and economic perspective. We studied the reasons for device replacement, the longevity of removed ICD, and the existence of possible factors associated with shorter service life. METHODS AND
RESULTS: Consecutive patients who underwent ICD replacement from March 2013 to May 2015 in 36 Italian centers were included in this analysis. Data on replaced devices were collected. A total of 953 patients were included in this analysis. In 813 (85%) patients the reason for replacement was battery depletion, while 88 (9%) devices were removed for clinical reasons and the remaining 52 because of system failure (i.e., lead or ICD generator failure or a safety advisory indication). The median service life was 5.9 years (25th-75th percentile, 4.9-6.9) for single- and dual-chamber ICD and 4.9 years (25th-75th percentile, 4.0-5.7) for CRT-D. On multivariate analysis, the factors CRT-D device, SC/DC ICD generator from Biotronik, percentage of ventricular pacing, and the occurrence of a system failure were positively associated with a replacement procedure. By contrast, the device from Boston Scientific was an independent protective factor against replacement. Considerable differences were seen in battery duration in both ICD and CRT-D. Specifically, Biotronik devices showed the shortest longevity among ICD and Boston Scientific showed the longest longevity among CRT-D (log-rank test, P < 0.001 for pairwise comparisons).
CONCLUSION: Several factors were associated with shorter service life of ICD devices: CRT-D, occurrence of system failure and percentage of ventricular pacing. Our results confirmed significant differences among manufacturers.
© The Authors. Journal of Cardiovascular Electrophysiology published by Wiley Periodicals, Inc.

Entities:  

Keywords:  Battery; CRT; implantable defibrillator; longevity

Mesh:

Year:  2016        PMID: 27094359     DOI: 10.1111/jce.12990

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  12 in total

1.  Repeated procedures at the generator pocket are a determinant of implantable cardioverter-defibrillator infection.

Authors:  Eduardo Arana-Rueda; Alonso Pedrote; Manuel Frutos-López; Juan Acosta; Beatriz Jauregui; Lorena García-Riesco; Álvaro Arce-León; Federico Gómez-Pulido; Juan A Sánchez-Brotons; Encarnación Gutiérrez-Carretero; Arístides de Alarcón-González
Journal:  Clin Cardiol       Date:  2017-06-21       Impact factor: 2.882

2.  Plasticity of left ventricular function with cardiac resynchronization therapy.

Authors:  Hong-Xia Niu; Yi-Ran Hu; Wei Hua; Min Gu; Jing Wang; Michael R Gold; Shu Zhang
Journal:  J Interv Card Electrophysiol       Date:  2019-05-28       Impact factor: 1.900

3.  Impact of quadripolar LV leads on heart failure hospitalization rates among patients implanted with CRT-D: data from the Israeli ICD Registry.

Authors:  Eran Leshem; Mahmoud Suleiman; Avishag Laish-Farkash; Moti Haim; Michael Geist; David Luria; Michael Glikson; Ilan Goldenberg; Yoav Michowitz
Journal:  J Interv Card Electrophysiol       Date:  2017-12-23       Impact factor: 1.900

4.  "Real life" longevity of implantable cardioverter-defibrillator devices.

Authors:  Antonis S Manolis; Themistoklis Maounis; Spyridon Koulouris; Vassilios Vassilikos
Journal:  Clin Cardiol       Date:  2017-05-22       Impact factor: 2.882

5.  Device runtime and costs of cardiac resynchronization therapy pacemakers - a health claims data analysis.

Authors:  Moritz Hadwiger; Nikolaos Dagres; Gerhard Hindricks; Helmut L'hoest; Ursula Marschall; Alexander Katalinic; Fabian-Simon Frielitz
Journal:  Ger Med Sci       Date:  2022-03-04

6.  Favorable Trend of Implantable Cardioverter-Defibrillator Service Life in a Large Single-Nation Population: Insights From 10-Year Analysis of the Italian Implantable Cardioverter-Defibrillator Registry.

Authors:  Stefano Poli; Giuseppe Boriani; Massimo Zecchin; Domenico Facchin; Maurizio Gasparini; Maurizio Landolina; Renato Pietro Ricci; Corrado Lanera; Dario Gregori; Alessandro Proclemer
Journal:  J Am Heart Assoc       Date:  2019-07-25       Impact factor: 5.501

7.  Longevity decoded: Insights from power consumption analyses into device construction and their clinical implications.

Authors:  Ernest W Lau
Journal:  Pacing Clin Electrophysiol       Date:  2019-03-05       Impact factor: 1.976

8.  Effect of battery longevity on costs and health outcomes associated with cardiac implantable electronic devices: a Markov model-based Monte Carlo simulation.

Authors:  Jordana K Schmier; Edmund C Lau; Jasmine D Patel; Juergen A Klenk; Arnold J Greenspon
Journal:  J Interv Card Electrophysiol       Date:  2017-11-06       Impact factor: 1.900

Review 9.  The subcutaneous implantable cardioverter defibrillator--review of the recent data.

Authors:  Stacy B Westerman; Mikhael El-Chami
Journal:  J Geriatr Cardiol       Date:  2018-03       Impact factor: 3.327

Review 10.  Remote Monitoring of Implantable Cardioverter-Defibrillators, Cardiac Resynchronization Therapy and Permanent Pacemakers: A Health Technology Assessment.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2018-10-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.